Available in select U.S. states. Eligibility is determined by the provider. Compounded semaglutide and tirzepatide are not FDA-approved for weight loss. It is prescribed only when deemed medically appropriate by a licensed provider after review. Individual results vary significantly based on factors like adherence, diet, exercise, and health status. No guarantees of weight loss. GLP-1 medications like semaglutide may increase the risk of thyroid C-cell tumors based on animal studies; human risk is not confirmed. Services provided by licensed physicians/nurse practitioners in states served, e.g., CA, FL, and others, via telemedicine. Check your state's telemedicine laws. We prioritize your privacy and comply with HIPAA regulations for protected health information. Must be 18 or older.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
